VGLL1 and cancer: In endocrine therapy-resistance breast cancer, the VGLL1-TEAD complex induced EGFR expression and promoted growth of fulvestrant-resistance cancer cells (188). A VGLL2-NCOA2 fusion protein found in spindle cell rhabdomyosarcoma was found to strongly induce expression of TEAD downstream target genes (189).